SMOC2 mediates GLI1+ mesenchymal cell-driven fibrostenosis and predicts postoperative recurrence in Crohn's disease.

已完结 10 由 11111 发布于 2026/8/2 9:56:33

DOI:10.1136/gutjnl-2025-337952
作者：Danshu Wang,Xiangyu Zhao,Qidi Yang,Dehao Zhu,Yijing Liao,Yizhou Zhao,Sishen Sun,Jiaxin Wang,Haiming Zhuang,Shuowen Zhang,Xinyu Wang,Tianyi Che,Mingji Li,Yubei Gu,Jing Sun,Ningbo Wu,Youqiong Ye,Ren Mao
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1136/gutjnl-2025-337952

BMJ

Abstract：BACKGROUND Fibrostenosis is a common and disabling complication of Crohn's disease (CD) with no reliable early biomarkers, limited treatment options and high postoperative recurrence. OB

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:知网基于散射多视角深度学习和几何先验的遥感影像目标检测